| Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | |
| Cheng, Ann-Lii; Kang, Yoon-Koo; Chen, Zhendong; Tsao, Chao-Jung; Qin, Shukui; Kim, Jun Suk; Luo, Rongcheng; Feng, Jifeng; Ye, Shenglong; Yang, Tsai-Sheng | |
| 刊名 | LANCET ONCOLOGY
 |
| 2009 | |
| 卷号 | 10期号:1 |
| ISSN号 | 1470-2045 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4945671 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Cheng, Ann-Lii,Kang, Yoon-Koo,Chen, Zhendong,et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J]. LANCET ONCOLOGY,2009,10(1). |
| APA | Cheng, Ann-Lii.,Kang, Yoon-Koo.,Chen, Zhendong.,Tsao, Chao-Jung.,Qin, Shukui.,...&Guan, Zhongzhen.(2009).Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.LANCET ONCOLOGY,10(1). |
| MLA | Cheng, Ann-Lii,et al."Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial".LANCET ONCOLOGY 10.1(2009). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论